EdenTree Asset Management’s Boston Scientific BSX Stock Holding History

EdenTree Asset Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.62M	Sell	131,600 -25,000	-16%	-$1.36M	1.71%	25
2026 Q1	$9.82M	Buy	156,600 +95,100	+155%	+$7.61M	2.96%	8
2025 Q4	$5.86M	Sell	61,500 -6,400	-9%	-$627K	1.8%	21
2025 Q3	$6.63M	Hold	67,900	–	–	1.6%	23
2025 Q2	$7.29M	Sell	67,900 -14,630	-18%	-$1.48M	2.02%	21
2025 Q1	$8.32M	Sell	82,530 -33,045	-29%	-$3.33M	2.79%	14
2024 Q4	$10.3M	Sell	115,575 -1,600	-1%	-$141K	3%	6
2024 Q3	$9.82M	Sell	117,175 -3,125	-3%	-$246K	2.84%	8
2024 Q2	$9.27M	Sell	120,300 -14,242	-11%	-$1.04M	2.94%	9
2024 Q1	$9.21M	Sell	134,542 -21,733	-14%	-$1.4M	2.92%	10
2023 Q4	$9.03M	Buy	156,275 +29,275	+23%	+$1.56M	2.8%	11
2023 Q3	$6.71M	Hold	127,000	–	–	2.63%	14
2023 Q2	$6.87M	Buy	+127,000	New	+$6.63M	2.36%	17

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

EdenTree Asset Management's BSX Position: Q2 2026 in Review

EdenTree Asset Management reduced its Boston Scientific (BSX) stake by 16% in Q2 2026, selling an estimated $1.36M and leaving 131,600 shares worth $5.62M. The position accounts for 1.71% of the portfolio, ranked #25.

EdenTree Asset Management first reported a position in BSX in Q2 2023 and has held it in 13 quarters since. The position peaked at $10.3M in Q4 2024. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

EdenTree Asset Management held 131,600 shares of Boston Scientific worth $5.62M as of Q2 2026.
EdenTree Asset Management sold 25,000 Boston Scientific shares in Q2 2026, an estimated $1.36M.
Boston Scientific made up 1.71% of EdenTree Asset Management's portfolio in Q2 2026, its #25 holding.
EdenTree Asset Management first reported a position in Boston Scientific in Q2 2023 and has held it in 13 quarters since.
EdenTree Asset Management's Boston Scientific position peaked at $10.3M in Q4 2024.
1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on EdenTree Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.